Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01075607 · ClinicalTrials.gov registry record
Lymph Fluid and Blood Collection for Identification of Novel Biomarkers
A clinical trial, sponsored by Indiana University.
- Terminated
- Registry status
- 50
- Enrollment target
NCT01075607: Clinical Trial study, sponsored by Indiana University.
NCT01075607 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01075607 was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The objective of this study is to identify and validate metastasis protein markers in lymph collected from women with metastatic breast cancer. We will examine peripheral blood for the presence of these identified markers in order to develop a user friendly clinical test to detect metastasis and to evaluate response to therapy.
Primary Outcome
Lymph fluid collected at surgery; blood collected at surgery and then every 6 months for 5 years.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-04 |
| Est. Completion | 2022-04 |
Why NCT01075607 stopped before completion
NCT01075607 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01075607 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01075607 about?
NCT01075607 is a clinical study titled "Lymph Fluid and Blood Collection for Identification of Novel Biomarkers". The objective of this study is to identify and validate metastasis protein markers in lymph collected from women with metastatic breast cancer. We will examine peripheral blood for the presence of these identified markers in order to develop a user friendly clinical test to detect metastasis and to ...
What is the current status of trial NCT01075607?
This trial is currently terminated. The enrollment target is 50 participants. The study started on 2010-04. Estimated completion is 2022-04.
Who is sponsoring clinical trial NCT01075607?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia